Search by Drug Name or NDC

    NDC 00009-0395-14 Cleocin Hydrochloride 300 mg/1 Details

    Cleocin Hydrochloride 300 mg/1

    Cleocin Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pharmacia & Upjohn Company LLC. The primary component is CLINDAMYCIN HYDROCHLORIDE.

    Product Information

    NDC 00009-0395
    Product ID 0009-0395_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8
    Associated GPIs 16220020100120
    GCN Sequence Number 009340
    GCN Sequence Number Description clindamycin HCl CAPSULE 300 MG ORAL
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 40832
    HICL Sequence Number 004044
    HICL Sequence Number Description CLINDAMYCIN HCL
    Brand/Generic Brand
    Proprietary Name Cleocin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name clindamycin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name CLINDAMYCIN HYDROCHLORIDE
    Labeler Name Pharmacia & Upjohn Company LLC
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050162
    Listing Certified Through 2024-12-31

    Package

    NDC 00009-0395-14 (00009039514)

    NDC Package Code 0009-0395-14
    Billing NDC 00009039514
    Package 100 CAPSULE in 1 BOTTLE (0009-0395-14)
    Marketing Start Date 1970-05-22
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL df9a2a41-b132-4f43-8940-b2d773b1369a Details

    Revised: 11/2022